You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphocytic Leukemia, Chronic (Refractory)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

Not yet recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • TQB3909 tablet
  • Zhengzhou, Henan, China
  • +1 more
Jul 17, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Not yet recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • CC312
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 12, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Active, not recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Duarte, California
  • +2 more
Oct 7, 2022

Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

Not yet recruiting
  • Leukemia
  • +4 more
  • (no location specified)
Jul 27, 2022

Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • RP-3500 in combination with Olaparib
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 23, 2022

Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)

Active, not recruiting
  • Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
  • Acalabrutinib capsule
  • Ahmedabad, India
  • +12 more
Feb 2, 2023

Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

Recruiting
  • Chronic Lymphocytic Leukemia
    • Granada, Spain
    • +4 more
    Nov 8, 2023

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
    • +6 more
    • (no location specified)
    Apr 12, 2023

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 17, 2022

    Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

    Recruiting
    • Non Hodgkin Lymphoma
    • +2 more
    • Fully human anti CD19 CAR-T Cell Dose
    • +2 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Oct 4, 2022

    Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

    Recruiting
    • Recurrent Acute Lymphoblastic Leukemia
    • +15 more
    • Anti-CD19/CD20/CD22 CAR T-Cells
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 4, 2022

    Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

    Recruiting
    • Relapsed Non Hodgkin Lymphoma
    • +6 more
    • Cincinnati, Ohio
    • +4 more
    Aug 3, 2022

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

    Recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +4 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 22, 2022

    B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

    Suspended
    • B-cell Chronic Lymphocytic Leukemia
    • Alemtuzumab
    • Peking, Beijing, China
      Peking University Cancer Hospital
    Jun 15, 2022

    Chronic Lymphocytic Leukemia Trial in Lebanon (BNC105P, Ibrutinib)

    Completed
    • Chronic Lymphocytic Leukemia
    • BNC105P
    • Ibrutinib
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Jan 3, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • São Paulo, Brazil
      Hospital Israelita Albert Einstein
    Jan 20, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

    Not yet recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 10, 2022